Literature DB >> 18398158

No evidence for taxane/platinum pharmacogenetic markers: just lack of power?

Werner Vach, Troels K Bergmann, Kim Brøsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18398158     DOI： 10.1200/JCO.2007.15.7776

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.

Authors:  Maarten J Deenen; Annemieke Cats; Jos H Beijnen; Jan H M Schellens
Journal:  Oncologist       Date:  2011-06-09

2.  Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.

Authors:  Troels K Bergmann; Henrik Gréen; Charlotte Brasch-Andersen; Mansoor R Mirza; Jørn Herrstedt; Berit Hølund; Andreas du Bois; Per Damkier; Werner Vach; Kim Brosen; Curt Peterson
Journal:  Eur J Clin Pharmacol       Date:  2011-02-16       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.